-The Hindu Business Line The best way to celebrate Ambedkar As we celebrate BR Ambedkar’s 125th birth anniversary, it is important to remember that his vision of economic equality for dalits is still a distant dream. He had told the Constituent Assembly on November 25, 1949: “We are entering an era of political equality. But economically and socially we remain a deeply unequal society. Unless we resolve this contradiction, inequality will destroy...

-The Times of India NEW DELHI: After a parliamentary panel's report calling for reform, it is the turn of the international scientific community and healthcare experts to red flag the functioning of the Medical Council of India (MCI). A latest report in 'Lancet', a medical journal, has expressed concerns about the council and the state of regulation of medical education in India. Referring to several observations in the parliamentary standing committee report...

-The Indian Express Bedaquiline, which is a drug for Multi-Drug Resistant TB, is being introduced at six identified tertiary care centres across India. The Union Health Ministry has introduced Bedaquiline into the national tuberculosis (TB) programme. This was among several initiatives Health Minister J P Nadda launched on Monday. Bedaquiline, which is a drug for Multi-Drug Resistant TB, is being introduced at six identified tertiary care centres across India. The sites have...

-Livemint.com The government relies on for-profit big business to deliver public goods despite their inability to deliver Can we listen to the budget as an annual public statement by the government of its economic and social philosophy and intent? The centre abandoned five-year plans that earlier laid down a road map of where government policies are headed. The budget, then, is an important reality check of whether the government is literally...

-The Times of India NEW DELHI: In a move that could significantly bring down prices of expensive medicines, a high-level committee has recommended capping of trade margins for costly drugs at 35% of MRP (maximum retail price). The recommendations - part of a report submitted by an inter-ministerial committee - have been put in the public domain by the Department of Pharmaceuticals, inviting comments on the suggestions. The committee was set up...